Roles
Research Associate Professor
-
Biography
Victor D. Rosenthal, MD, PhD, is the Director of the Master of Public Health and Master of Science in Public Health programs and a Research Associate Professor in the Department of Public Health Science at the University of Miami Miller School of Medicine, where he teaches Infectious Disease Epidemiology and also serves as a graduate student advisor.
He is a medical doctor with a residency in internal medicine, a fellowship in infectious diseases, a PhD in epidemiology, and certification in infection control and clinical effectiveness programs. He was a visiting professor at the University of Wisconsin, where he taught epidemiology and the prevention of healthcare-associated infections (HAI).
In addition, he is the Editor-in-Chief of the U.S. Infusion Therapy and Vascular Access Standards of Practice, which include 9 sections with 65 standards and are published every 3 years following a review of approximately 3,000 scientific papers to update them. He is also the Editor and First Author of the Infection Prevention Guidelines of the International Society for Infectious Diseases. He is also a member of the Florida Department of Health Priority Area Workgroup for Transmissible and Emerging Diseases in the USA.
He is the Founder and Chief Scientific Officer of the International Nosocomial Infection Control Consortium (INICC) Foundation, a U.S. 501(c)(3) nonprofit research center focused on the surveillance, prevention, and control of HAIs in low- and middle-income countries. Since 2002, in this role, he has led research efforts in collaboration with more than 2,500 researchers across hundreds of cities in over 45 countries in Asia, Africa, Eastern Europe, and Latin America.
Over the past 35 years, he has dedicated himself full-time to HAIs, Patient Safety, Healthcare Quality, and the development of online platforms for HAI surveillance, prevention, and control, providing volunteer pro bono support to low- and middle-income countries. Over the past 3 decades, Dr. Rosenthal has spoken at thousands of conferences and symposia in 71 countries across Asia, Africa, Europe, North America, Latin America, and Oceania. He is the author of more than 450 scientific publications and book chapters, 158 of which are indexed in PubMed at the U.S. National Library of Medicine, National Institutes of Health, including publications in The Lancet, Annals of Internal Medicine, Critical Care Medicine, Clinical Infectious Diseases, and several other high-impact journals. According to Google Scholar, he has accumulated 37,000 total citations and has an h-index of 74.
He has received 10 major international awards for research excellence, including the Blue-Ribbon Award, the Best International Abstract Award, the Association for Professionals in Infection Control and Epidemiology of America (APIC) Award for Publication Excellence, and the Society for Hospital Epidemiology of America (SHEA) William Jarvis Award.
Since 2007, he has authored multiple chapters for Bennett & Brachman’s Hospital Infections, the most widely sold and utilized book on HAI prevention in the United States and worldwide. He has also contributed chapters on HAIs to books published in Argentina, Colombia, India, and several other countries.
He has played a critical role in several distinguished organizations, including Oxford University in the United Kingdom, where he has conducted multicenter research and produced peer-reviewed scientific publications on bacterial resistance; St George University in the United Kingdom, where he has conducted multicenter research on HAIs in pediatric and neonatal intensive care units; Washington University in Seattle, USA, where he has conducted multicenter research on bacterial resistance; Washington University in St. Louis, USA, as a member of a scientific trials panel; the Joint Commission International, USA, as a task force member for bloodstream infection prevention guidelines and as an author of a chapter in the book of best practices in infection prevention and control; the Centers for Disease Control and Prevention (CDC), USA, by developing online software for global surveillance of multidrug-resistant tuberculosis; the World Health Organization, as a reviewer of hand hygiene and multidrug-resistant microorganism guidelines and by providing primary data for its meta-analysis on surgical site infections; the Ministries of Health of Hong Kong, Taiwan, and Colombia, by collaborating on guideline development to prevent HAIs; the Ministry of Health and the Senate of Argentina, by serving as a consultant and editor of national guidelines for healthcare-associated infection prevention; the Ministry of Health of Italy and the Swiss National Foundation, by reviewing research grant applications; and the International Society of Infectious Diseases, by editing guidelines to prevent HAIs.
He currently serves as an Editorial Board Member of the American Journal of Infection Control, the Journal of Infection and Public Health, and the Annals of Clinical Microbiology and Antimicrobials. He also serves as a peer reviewer for more than 100 PubMed-indexed peer-reviewed journals, including The Lancet and many others. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
No result found
-
Research Interests
Surveillance, Prevention, and Control of Health Care-Associated Infections and Multi-Drug Resistant Organisms -
Publications
Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.
